Corey Miller
Washington University in St. Louis(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Liver Disease Diagnosis and Treatment, Regulation of Appetite and Obesity, Neuropeptides and Animal Physiology, Pancreatic function and diabetes
Most-Cited Works
- → Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice(2009)405 cited
- → Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes(2011)146 cited
- → The Glucagon Receptor Is Involved in Mediating the Body Weight‐Lowering Effects of Oxyntomodulin(2012)106 cited
- → Discovery of a Novel Glucagon Receptor AntagonistN-[(4-{(1S)-1-[3-(3, 5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the Treatment of Type II Diabetes(2012)86 cited
- → Anti-Diabetic Efficacy and Impact on Amino Acid Metabolism of GRA1, a Novel Small-Molecule Glucagon Receptor Antagonist(2012)50 cited
- → Taurine allosterically modulates flunitrazepam binding to synaptic membranes(1992)25 cited
- → The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys(2016)24 cited
- → A novel series of indazole-/indole-based glucagon receptor antagonists(2015)16 cited
- → Correction: The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys(2017)2 cited